View Older Stories View More Recent Stories
-
Vista Gold Corp. Announces Closing of $13.5 Million Bought Deal Offering
-
Daqo New Energy (DQ) PT Lowered to $73 at Roth Capital
-
Roth CH Acquisition II Co. Announces Special Meeting Date Set for July 27, 2021 to Approve Proposed Merger with Reservoir
-
Lakeshore Acquisition I Corp. Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing July 22, 2021
-
3 Former Penny Stocks To Watch This Week As Earnings Season Kicks Off
-
Roth Capital Starts Nouveau Monde Graphite Inc. (NMG) at Buy
-
Vista Gold Corp (VGZ) Upsizes Bought Deal Offering to $13.5M
-
Vista Gold Corp. Increases Previously Announced Bought Deal Offering to $13.5 Million
-
Vista Gold Corp. Increases Previously Announced Bought Deal Offering to $13.5 Million
-
Robinhood Opens Up IPO Access for Mark Wahlberg-Backed F45 Training (FXLV)
-
Roth Capital Downgrades Denbury Inc. (DEN) to Neutral
-
UPDATE: Roth Capital Starts Zeta Global Holdings Corp (ZETA) at Buy
-
Better Choice Announces Closing of $40M Underwritten Public Offering
-
RegeneRx Biopharmaceuticals, Inc. Closes $2 Million Private Placement
-
InvestorNewsBreaks — Celsius Holdings Inc. (NASDAQ: CELH) Closes on $463M Public Offering
-
Netlist (NLST) PT Raised to $6 at Roth Capital
-
Franklin Covey (FC) First Look, Sub Model Has Reached Critical Mass - Roth Capital
-
Unicycive Therapeutics, Inc (UNCY) Announces 4.55M Share IPO at $5-$6/sh
-
Purple Innovation (PRPL) PT Lowered to $31 at Roth Capital
-
Best Penny Stocks For Your July 2021 List? 8 Biotechs To Watch Now
-
Riley Exploration Permia (REPX) Prices 1.7M Offering at $30/sh
-
Riley Exploration Permian, Inc. Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Research Solutions Inc. (RSSS) at Buy
-
DiaMedica Therapeutics Inc. (DMAC) PT Lowered to $32 at Roth Capital
-
Better Choice Company (BTTR) Prices 8M Share Offering at $5/sh
-
Better Choice Announces Pricing of Public Offering of Common Stock
-
RegeneRx Biopharmaceuticals, Inc. Announces $2 Million Private Placement
-
BioMedNewsBreaks – InvestorBrandNetwork Heightening Visibility, Widening Reach of Roth Capital Partners’ Healthcare Private Company Forum
-
Roth Capital Partners’ Virtual Healthcare Private Company Forum to Focus on Biotechnology, Pharmaceuticals and Medical Technologies
-
7 Hot Penny Stocks Analysts Like To Watch In 2021
-
InvestorBrandNetwork (IBN) is Serving as Official Media Sponsor for Roth Capital Partners’ Healthcare Private Company Forum
-
Intellia Therapeutics (NTLA) PT Raised to $110 at Roth Capital After First In-Person Data with a Clean Safety Profile
-
UPDATE: Roth Capital Starts BioAtla Inc. (BCAB) at Buy
-
META Closes Transaction and Commences Trading on NASDAQ
-
UPDATE: Roth Capital Starts Panbella Therapeutics (PBLA) at Buy
-
InvestorNewsBreaks – Roth Capital Partners’ Upcoming Event to Feature Latest Trends in Biotechnology, Pharmaceuticals and Medical Technologies
-
Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021
-
Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021
-
9 Hot Penny Stocks To Watch Right Now, Analyst Targets Up To 290%
-
Nouveau Monde Announces Closing of US$59.4 Million Public Offering of Common Shares in the United States and Canada
-
Nouveau Monde Announces Closing of US$59.4 Million Public Offering of Common Shares in the United States and Canada
-
UPDATE: Roth Capital Starts Climate Change Crisis Real Impact Acquisition Corp. (CLII) at Buy
-
8 Hot Biotech Penny Stocks For Your July 2021 Watch List
-
Best Solar Stocks to Invest in 2021? Wall Street Weighs In
-
Torchlight Energy Resources (TRCH) updated its prospectus to sell another $150 million in common stock through Roth Capital
-
Novan Announces Closing of $40 Million Public Offering of Common Stock
-
FalconStor Software Announces Pricing of its Public Offering of Common Stock
-
UPDATE: Roth Capital Starts Spartan Acquisition Corp II (SPRQ) at Buy
-
10 Top Penny Stocks On Robinhood To Watch Right Now Before July 2021
-
RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
